Patterns of heart rate variability responses to acute skin-breaking procedures in neonates: a systematic review and meta-analysis.

PainJun 17, 2026 (epub)
Clinical ResearchPediatrics

Oana Bucsea, Sara Jasim, Estreya Cohen et al.

✦ AI-curated · Sources linked

In 30 seconds

This systematic review and meta-analysis examined heart rate variability (HRV) responses to acute skin-breaking procedures in preterm and full-term newborns within the first month of life. A total of 32 studies were included, with 27 undergoing meta-analysis. The findings revealed significant variability in HRV patterns related to acute pain responses, influenced by gestational and postnatal age.

Key findings

  • Gestational and postnatal age significantly affect HRV patterns of acute pain-related stress reactivity.
  • There is variability in acute pain-related stress reactivity across different HRV measures.
  • Normative patterns of pain-related stress regulation were identified through HRV analysis.
  • Substantial heterogeneity and risk of bias were noted across the included studies.

Why it matters

Understanding HRV responses to pain in newborns can inform clinical practices for pain management in this vulnerable population, potentially leading to improved outcomes and care strategies.

What to keep in mind

Substantial heterogeneity and risk of bias across studies were significant limitations in the current review.

Source

Published in Pain. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Pediatrics

Clinical ResearchOncology (Medical)

Zamtocabtagene autoleucel, a tandem CD20-CD19-directed CAR T-cell therapy, for second line treatment of large B-cell lymphoma in patients ineligible for transplantation (DALY 2-EU): primary analysis of an open-label, multicentre, randomised phase 2 study.

DALY 2-EU was an open-label, multicentre, randomised phase 2 trial comparing tandem CD20-CD19-directed zamtocabtagene autoleucel (zamto-cel) with R-GemOx in adults with second-line relapsed or refractory large B-cell…

Lancet OncolOct 27, 2026Read summary
Clinical ResearchOncology (Medical)

Neoadjuvant short-course radiotherapy followed by camrelizumab and chemotherapy versus standard of care for locally advanced rectal cancer (UNION): a prespecified interim analysis of a multicentre, open-label, randomised, phase 3 trial.

UNION was a multicentre, open-label, randomised phase 3 trial at nine hospitals in China comparing neoadjuvant short-course radiotherapy followed by camrelizumab plus CAPOX with long-course chemoradiotherapy followed by…

Lancet OncolOct 25, 2026Read summary
Clinical ResearchHematology

Efficacy and safety of mitapivat in patients with sickle cell disease (RISE UP): a phase 3, double-blind, global, randomised, placebo-controlled trial.

RISE UP was a phase 3, double-blind, global, randomised, placebo-controlled trial conducted at 69 sites in 15 countries. It evaluated twice-daily mitapivat in patients older than 16 years with sickle cell disease…

LancetOct 24, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.